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An Examination of Three Model Healthcare Delivery Systems 
Gavin Stern 
The United States is just now beginning its journey into a universal healthcare delivery sys-
tem. On March 30, 2010, President Obama signed into law the “Health Care and Education 
Reconciliation Act of 2010” (H.R. 4872), which completed the work of the “Patient Protection 
and Affordable Care Act” (H.R. 3590) signed on March 23, 2010. The effects of this legislation 
are phased in over the course of this new decade, but the final product is far from certain. Im-
plementation could be legislated away with one election cycle. This article examines three 
model healthcare delivery systems that the United States could look towards on its march to 
universal coverage: those of France, Germany, and the Netherlands. 
France: Government-run Universal Insurance 
In 2000, France had the best healthcare system in the world, according to the World Health 
Organization.1 The basic French system - Sécurité Sociale - covers “Hospital care, ambulatory 
care and prescription drugs” along with “minimal coverage of outpatient eye and dental care” 2 
and “nursing home benefits.”1 This is a mandatory system. 
“Complementary insurance” covers individual cost 
sharing, and is usually provided by the employer. More 
recently, the Couverture Maladie Universelle (CMU) is 
provided to individuals who cannot afford the public 
system due to unemployment2, estimated at 0.4% of the 
population. Another system L’Aide Medicale d’Etat 
(AME) covers “Illegal residents.” In general, “poorer 
patients are exempt from cost-sharing.”2 Therefore, one 
could infer that that none go without basic health insur-
ance in France – even noncitizens.1 
The French medical system is not nearly as government-centralized as, for instance, the 
United Kingdom, which has a socialized system. Rather, the government of France finances 
basic healthcare via legislation “that creates the annual prospective global budget for the public 
health expenditures,” which “funds the Sécurité Sociale and CMU and is financed through na-
tional income taxes and the General Social Tax – a supplementary income tax (7.5%) intro-
duced in 1991 to help offset health care costs; 5.25% of which helps pay for the health care sys-
tem.” Further, “Complementary insurance” reduces financial burden on individual cost sharing. 
Ninety-two percent of the population carries the complementary insurance, “roughly half of 
which is funded by employers.”1 
France controls healthcare costs with financial leverage. For instance, individual co-
payment for a drug is linked to effectiveness. Drugs with proven therapeutic effects are basi-
cally free, while those of dubious or limited use are cost-shared to a greater extent. While indi-
viduals may visit any physician, reimbursements are better when one starts with a gatekeeper 
general practitioner: “Visits to the gatekeeping general practitioner are subject to a 30% co-
insurance rate, while visits to other GPs are subject to a 50% co-insurance rate.”2 This is a new 
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concept, introduced via the Douste-Blazy law in order to reduce large budget deficits. Overall, 
the practice of medicine in France is a “self-regulating market.” A “reference price” determines 
what the public system will reimburse. Technology reduces paperwork and increases efficiency: 
“patients carry Sécurité Sociale cards containing microchips storing their comprehensive medi-
cal information, allowing physicians immediate access to a patient’s record.” Physicians are 
private employees, “mostly self-employed and paid on a fee-for-service basis.”1 
Out of pocket spending for healthcare is still an issue in France, as “patients visiting physi-
cians and dentists pay full price and are later reimbursed for costs by the public health insurance 
and complementary insurance.” Out of pocket expenses were 6.9% of total health expenditures 
in 2005.1 However, some conditions are completely reimbursed, “including cancer, diabetes and 
other chronic conditions… includ[ing] all pharmaceuticals [and] experimental drugs.” Pricing 
and reimbursements are “negotiated between the health insurance funds and unions representing 
providers.” The supplemental insurance plans “are not allowed to compete by lowering health 
insurance premiums”,1  which may have the effect of reducing competition but is done for the 
purposes of solidarity. To reduce the effects of moral hazard, there are additional co-payments 
per office visit, with an annual ceiling of 50 Euros. The French system in totality does not pro-
vide the same level of expertise to all income levels, as “doctors and dentists may charge above 
this reference price based on their level of professional experience.”2 The wealthy, then, can 
afford more skilled practitioners despite the French principle of solidarity.  However, the ability 
for skilled physicians to set a higher price also provides an incentive to achieve that higher level 
of skill – a capitalist tenet. 
Is the French healthcare system a good deal? Healthcare spending in France was 11.1% of 
GDP in 2005, much lower than 15.3% in the United States.3 Per capita spending in 2003 was 
$2903 in France compared to $5635 in the United States. There are proportionally more physi-
cians in France: 3.4 to 2.3 per 1000.4 French infant mortality was 4.3 deaths per 1000 births 
compared to 7.2 per 1000, and life expectancy at birth was 82.2/74.6 (female/male) compared 
to 79.4/73.9 in the United States.5 Clearly, the French system performs better. However, US 
implementation of the French system would be difficult because it requires a strong central gov-
ernment (France is arguably a single-payer system). A system of government-regulated insur-
ance coverage (more like that of Germany or the Netherlands) might be a more reasonable long-
term goal for the United Statess 
Germany: Social Insurance and Sickness Funds 
 The healthcare system of Germany consists of governmentally independent sickness funds, 
along with a separate private insurance system. Sickness funds are “autonomous, not for profit, 
nongovernmental bodies regulated by law,” which act as “the collectors, purchasers, and payers 
in both health and long-term care insurance” in Germany. 6 This system of more than 200 sick-
ness funds is “the oldest system of social insurance in the world.”7 The notion is that these 
funds will compete against one another, encouraging greater efficiency and reduced cost. 
In 2006, 88% of Germans were covered by the sickness fund system. Only 0.22% of Ger-
mans were uninsured. A “special state program” covered 9.7% as government employees, and 
2% purchased private health insurance.7 Individuals with income levels of less than 48,000 
annually (75% of the German population) are required to enter into the public program. 75% of 
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people with income above this level remain in the public system by choice. This helps to dem-
onstrate that the public healthcare system of Germany is considered to be satisfactory even for 
those with greater income levels, as private insurance enrollment is very low. After 2009, 
“health insurance will be mandatory” in “either the social or private health insurance scheme.”6 
Before that, insurance was optional for individuals with yearly income over  48,000. 
The sickness funds are financed by employee and employer contributions of (on average) 
8% and 7% of income, respectively. The unemployed are still expected to make a contribution. 
Patients may incur cost sharing or copayments of up to “2% of household income.” This figure 
is cut in half for those declared “chronically ill.” This system of contribution also changes in 
2009, in that “all contributions will be centrally pooled by a new national health fund, which 
will allocate resources to each [sickness fund] based on an improved risk-adjusted capitation 
formula.”6 This should help to evenly spread the risk of more ill, more needy, more expensive 
patients on particular sickness funds. However, this does show a trend towards more centralized 
control via the government. 
The sickness fund program is more comprehensive than other social health programs dis-
cussed in this analysis – including, “dental, inpatient, and preventive care” along with 
“prescription drugs and rehabilitative treatments” and disability payments to those who cannot 
work.”7 Patients receive incentives to utilize gen-
eral practitioners in a “family physician care 
model.” The German system encourages cost ef-
fectiveness as sickness funds and physicians col-
laborate on price control. Physicians maintain their 
autonomy to practice and are generally “paid by a 
mixture of fees per time period and per medical 
procedure.”6 Physicians are compensated “by sick-
ness funds via their regional physician associa-
tions.”8 It should be noted that, unlike the United 
States system, physicians are encouraged to col-
laborate and lobby, similar to the French system. 
Healthcare spending in Germany was 10.7% of 
GDP in 2005, lower than 15.3% in the United 
States and 11.1% for France.3 Per capita spending in 2003 was $2996 in Germany, much lower 
than $5635 in the United States. Germany and France had the same per capita number of physi-
cians at 3.4 per 1000, higher than 2.3 per 1000 in the United States.4 German infant mortality 
was 4.6 deaths per 1000 births in 1999 (7.2 per 1000 in the US) while life expectancy at birth in 
1998 was 80.5/74.5 (female/male) compared to 79.4/73.9 in the United States.5 The German 
healthcare model receives generally good reviews, with 66% of Germans approving of the sys-
tem in 1996,5 and 11% disapproving.8 The German system would be difficult to implement in 
the United States because it involves a large degree of government control. The sickness funds 
do not operate capitalistically (as in the Netherlands) but rather as a nonprofit, indirect exten-
sion of government. 
The German healthcare system significantly outperforms that of the United States, with re-
sults comparable to France but with less expenditure as a percentage of GDP. American imple-
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mentation of the German system is feasible because the sickness funds are analogous to private 
insurance companies. However, the German system requires these funds to be not-for-profit, 
and they now pay into a single national fund. Employers would have to contribute to the sys-
tem, a policy that United States has been trending away from. While a system similar to that of 
Germany could practically evolve in the United States by capping insurance company profits, 
the political reality is that it would be attacked as anti-capitalist. The healthcare system of the 
Netherlands might be more palatable. 
 The Netherlands: Multi-Payer Private Competition With Government Regulation 
The Dutch healthcare system has been referenced as a possible route to universal healthcare 
coverage in the United States.9 The Health Insurance Act (2006) established a system of gov-
ernment-regulated private insurance companies. As in the United States, insurers retain their for
-profit status. However, in the Netherlands the Supervisory Board For Health regulates these 
companies. The emerging American model may benefit from the Dutch example of increased 
regulation. 
The Dutch government does not exert 
direct control over healthcare treatments 
(no rationing). Rather, insurance compa-
nies are obligated to accept anyone who 
applies for the government-mandated 
standard insurance package. Each policy 
must include basic services: “medical 
care… hospitals and midwives, hospitali-
zation… medical aids, medicines, mater-
nity care, ambulance and patient transport 
services” as well as limited remedial, 
speech, and occupational therapy. Nurs-
ing care, home care, chronic and mental 
illnesses are covered under the separate 
Exceptional Medical Expenses Act. All 
working adult citizens of the Netherlands 
are obligated to purchase a standard in-
surance policy. The government pays for 
the health policies of children (under 18 years of age). The government also subsidizes indi-
viduals who cannot afford such a policy, defined as greater than 5% of income, by providing an 
allowance proportionate to income. Nevertheless, an estimated 1.5% of Dutch citizens remained 
uninsured as of 2007.10 The lack of 100% coverage remains a consequence of blunted govern-
ment intervention, an issue that the United States will also be left with. 
Individuals, employers, and the government finance the Dutch system. Individuals pay 
“6.5% of the first 30,000 of annual taxable income.” The rate is reduced to 4.4% for the un-
employed. Purchasers of these policies retain free choice, in that they may change policies once 
per year. Citizens also benefit from lowered prices as insurers compete for business. This com-
petition-based model also forces increased efficiency and cost reduction. Physicians operate on 
a fee for service basis. General practitioners “receive a capitation payment for each patient on 
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their practice list and a fee per consultation,” a vast improvement over American reimburse-
ment for primary care services. Physicians maintain their autonomy, in that they are not em-
ployees of the government. The billing process is simplified via Diagnosis Treatment Combina-
tions (DTCs). DTCs incorporate all the costs of treatment and diagnosis, so that individuals do 
not receive billings for every minute detail in a single office visit. 10 
Insurance companies charge a “flat rate premium,” which is based on the policy itself – not 
the risk of the insured as in the American system. The cost of these annual premiums was 
1,050 on average in 2006. Government-mandated deductibles have been in effect since 2007, 
and the insured pay “the first 150 of any health care costs in a given year.” However, costs to 
the individual remain low, as “out of pocket payments as a proportion of total health expendi-
ture are around 8%.” Payments “are collected centrally and distributed among insurers based on 
a risk-adjusted capitation formula” in order to equilibrate risk. 10 
Healthcare spending in the Netherlands was 9.2% of GDP in 2004, lower than the United 
States, France, and Germany.3 Per capita spending in 2003 was $2,976. The Netherlands em-
ployed slightly fewer physicians per capita (3.1 per 1000) than Germany and France, but still 
outperformed the United States.4 Dutch infant mortality was 4.3 deaths per 1000 births, and life 
expectancy at birth was 82.1 for females and 76.8 for males – rates almost unanimously equal 
or better than all countries compared in 
this analysis.11 
This system is far from perfect. Al-
though the Dutch system encourages com-
petition and free choice, “four insurers 
control 90% of the market.” Additionally, 
the basic healthcare package does not 
cover what Americans might consider to 
be essential services, such as dental care, 
eyeglasses, alternative therapies, and cos-
metic surgery (in some cases of disfigure-
ment). Citizens still have to pay extra for 
these services. Indeed, “90% [of citizens] 
buy supplemental packages.” 
The Future of The United States: 
Of the healthcare systems examined in this analysis – France, Germany, and the Nether-
lands – the Dutch model is most compatible with the emerging healthcare system adopted by 
the United States in 2010. The Dutch model produces the best results at the lowest price, with a 
high degree of freedom and coverage while retaining capitalistic principles. The United States 
would do well to follow the path of mandated coverage and strong government regulation of 
insurance companies. There is some optimism that the United States may be moving in this di-
rection. Those who support such a system and the benefits outlined herein will need to be vigi-
lant of insurance companies that defend profit, of misplaced political accusations, and a politi-
cal movement to repeal this reform or declare it unconstitutional. 
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